HK1143404A1 - Cell for use in the production of exogenous protein, and production process using the cell - Google Patents

Cell for use in the production of exogenous protein, and production process using the cell

Info

Publication number
HK1143404A1
HK1143404A1 HK10109823.2A HK10109823A HK1143404A1 HK 1143404 A1 HK1143404 A1 HK 1143404A1 HK 10109823 A HK10109823 A HK 10109823A HK 1143404 A1 HK1143404 A1 HK 1143404A1
Authority
HK
Hong Kong
Prior art keywords
cell
production
exogenous protein
production process
exogenous
Prior art date
Application number
HK10109823.2A
Other languages
English (en)
Inventor
Hisahiro Tabuchi
Satoshi Tainaka
Tomoya Sugiyama
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of HK1143404A1 publication Critical patent/HK1143404A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/303—Liver or Pancreas
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HK10109823.2A 2007-10-24 2010-10-18 Cell for use in the production of exogenous protein, and production process using the cell HK1143404A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007276182 2007-10-24
PCT/JP2008/069184 WO2009054433A1 (ja) 2007-10-24 2008-10-23 異種タンパク質製造のための細胞及びそれを用いた製造方法

Publications (1)

Publication Number Publication Date
HK1143404A1 true HK1143404A1 (en) 2010-12-31

Family

ID=40579535

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10109823.2A HK1143404A1 (en) 2007-10-24 2010-10-18 Cell for use in the production of exogenous protein, and production process using the cell

Country Status (15)

Country Link
US (1) US9068212B2 (ko)
EP (1) EP2213746B1 (ko)
JP (1) JP5337044B2 (ko)
KR (1) KR101636086B1 (ko)
CN (1) CN101821403B (ko)
AU (1) AU2008314973C1 (ko)
BR (1) BRPI0818764B1 (ko)
CA (1) CA2703493C (ko)
DK (1) DK2213746T3 (ko)
ES (1) ES2548294T3 (ko)
HK (1) HK1143404A1 (ko)
MX (1) MX2010004397A (ko)
RU (1) RU2494148C2 (ko)
TW (1) TWI434935B (ko)
WO (1) WO2009054433A1 (ko)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101421411B (zh) 2006-04-13 2015-06-03 中外制药株式会社 牛磺酸转运蛋白基因
EP2135946B1 (en) * 2007-03-15 2015-12-09 Chugai Seiyaku Kabushiki Kaisha Method for production of polypeptide
WO2009020144A1 (ja) 2007-08-07 2009-02-12 Chugai Seiyaku Kabushiki Kaisha 異種タンパク質の製造方法
BRPI0818039A2 (pt) 2007-10-15 2014-10-14 Chugai Pharmaceutical Co Ltd Método para produzir uma célula capaz de produção de alto rendimento de heteroproteínas.
EP2213746B1 (en) 2007-10-24 2015-07-15 Chugai Seiyaku Kabushiki Kaisha Cell for use in the production of exogenous protein, and production process using the cell
JP5715050B2 (ja) * 2009-04-22 2015-05-07 中外製薬株式会社 異種タンパク質を高生産する細胞の作製方法
US8722387B2 (en) * 2011-02-28 2014-05-13 Novozymes, Inc. Microorganisms for C4-dicarboxylic acid production
ES2620306T3 (es) * 2011-04-01 2017-06-28 Chugai Seiyaku Kabushiki Kaisha Método de producción de polipéptido recombinante
US9675171B2 (en) * 2012-10-05 2017-06-13 Lamplight Farms Incorporated Outdoor appliance with retractable platform
WO2014058025A1 (ja) 2012-10-10 2014-04-17 中外製薬株式会社 改変宿主細胞の樹立方法
EP3180422B2 (en) * 2014-08-11 2021-11-17 F. Hoffmann-La Roche AG Method for increasing the specific production rate of eukaryotic cells
CN107287178B (zh) * 2016-04-12 2019-10-29 中国科学院微生物研究所 Csad蛋白及其编码基因在抗流感病毒中的应用
JP7123168B2 (ja) * 2018-12-11 2022-08-22 富士フイルム株式会社 動物細胞、動物細胞の製造方法および目的タンパク質の製造方法

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59184841A (ja) * 1983-04-05 1984-10-20 ベクトン・デイツキンソン・アンド・カンパニ− サンプル中の白血球のサブクラスを識別する方法および装置
GB9019812D0 (en) * 1990-09-11 1990-10-24 Scotgen Ltd Novel antibodies for treatment and prevention of infection in animals and man
US6225115B1 (en) 1992-03-04 2001-05-01 Synaptic Pharmaceutical Corporation DNA encoding taurine and GABA transporters and uses thereof
AU691469B2 (en) 1992-03-04 1998-05-21 Synaptic Pharmaceutical Corporation DNA encoding taurine and gaba transporters and uses thereof
TW402639B (en) 1992-12-03 2000-08-21 Transkaryotic Therapies Inc Protein production and protein delivery
JP3630453B2 (ja) 1994-09-30 2005-03-16 中外製薬株式会社 Ｉｌ−６レセプター抗体を有効成分とする未熟型骨髄腫細胞治療剤
AU695117B2 (en) 1994-10-06 1998-08-06 Hoechst Aktiengesellschaft Regulated genes by stimulation of chondrocytes with IL-1beta
JPH09203734A (ja) 1996-01-26 1997-08-05 Sumitomo Electric Ind Ltd 抗血清、抗体、リガンド及びそれらの検出方法
JPH1075787A (ja) 1996-09-02 1998-03-24 Asahi Chem Ind Co Ltd 変異型アラニンアミノトランスフェラーゼおよびその製造法
JPH10191984A (ja) 1997-01-09 1998-07-28 Oriental Yeast Co Ltd 活性型ヒトａｌｔの製造法
DE19855313A1 (de) 1998-12-01 2000-06-08 Degussa Verfahren zur fermentativen Herstellung von D-Pantothensäure durch Verstärkung des panD-Gens in Mikroorganismen
ATE363074T1 (de) 1999-09-14 2007-06-15 Xenoport Inc Substrate und screeningverfahren für transportproteine
US6812339B1 (en) 2000-09-08 2004-11-02 Applera Corporation Polymorphisms in known genes associated with human disease, methods of detection and uses thereof
WO2002092768A2 (en) 2001-05-14 2002-11-21 University Of Maryland, Baltimore Novel alanine transaminase enzyme and methods of use
IL161677A0 (en) 2001-11-08 2004-09-27 Protein Design Labs Stable liquid pharmaceutical formulation of igg antibodies
BR0307010A (pt) 2002-01-18 2006-04-11 Cargill Inc alanina 2,3-aminomutase
IL152905A0 (en) 2002-11-17 2003-06-24 Univ Ramot Dopaminergic markers induction in neuronal-like cells isolated from adult human bone marrow stromal cells: implications for novel gene therapy strategy for parkinsons disease
US20050265983A1 (en) 2002-11-17 2005-12-01 Eldad Melamed Methods, nucleic acid constructs and cells for treating neurodegenerative disorders
US20030165495A1 (en) 2003-04-01 2003-09-04 Carulli John P. Nucleic acids and polypeptides
US20050170391A1 (en) 2004-01-30 2005-08-04 Xenoport, Inc. TAUT1 transporters expressed in blood brain barrier cells
KR100789645B1 (ko) 2004-04-14 2007-12-27 주식회사유한양행 Ｂ형 간염바이러스의 ｓ-표면항원을 인식하는 인간화 항체및 이의 제조방법
EP2898897A3 (en) 2004-07-09 2015-10-14 Chugai Seiyaku Kabushiki Kaisha Anti-glypican 3 antibody
CA2522152A1 (en) 2004-10-07 2006-04-07 Kabushiki Kaisha Sangi Transdermal and transmucosal preparations
PE20061324A1 (es) 2005-04-29 2007-01-15 Centocor Inc Anticuerpos anti-il-6, composiciones, metodos y usos
US20070207152A1 (en) 2005-11-09 2007-09-06 Brophy Susan E Human BNP immunospecific antibodies
US8288611B2 (en) 2005-12-23 2012-10-16 Arcadia Biosciences, Inc. Nitrogen-efficient monocot plants
CN101421411B (zh) 2006-04-13 2015-06-03 中外制药株式会社 牛磺酸转运蛋白基因
EP2135946B1 (en) 2007-03-15 2015-12-09 Chugai Seiyaku Kabushiki Kaisha Method for production of polypeptide
WO2009020144A1 (ja) 2007-08-07 2009-02-12 Chugai Seiyaku Kabushiki Kaisha 異種タンパク質の製造方法
BRPI0818039A2 (pt) 2007-10-15 2014-10-14 Chugai Pharmaceutical Co Ltd Método para produzir uma célula capaz de produção de alto rendimento de heteroproteínas.
EP2213746B1 (en) 2007-10-24 2015-07-15 Chugai Seiyaku Kabushiki Kaisha Cell for use in the production of exogenous protein, and production process using the cell
JP5715050B2 (ja) 2009-04-22 2015-05-07 中外製薬株式会社 異種タンパク質を高生産する細胞の作製方法

Also Published As

Publication number Publication date
JP5337044B2 (ja) 2013-11-06
US20110014654A1 (en) 2011-01-20
RU2494148C2 (ru) 2013-09-27
RU2010120677A (ru) 2011-11-27
ES2548294T3 (es) 2015-10-15
AU2008314973B2 (en) 2014-01-09
KR20100082003A (ko) 2010-07-15
US9068212B2 (en) 2015-06-30
JPWO2009054433A1 (ja) 2011-03-03
CA2703493A1 (en) 2009-04-30
CN101821403B (zh) 2014-01-01
EP2213746A1 (en) 2010-08-04
TW200934870A (en) 2009-08-16
TWI434935B (zh) 2014-04-21
EP2213746B1 (en) 2015-07-15
BRPI0818764A2 (pt) 2015-04-22
AU2008314973C1 (en) 2014-05-08
DK2213746T3 (en) 2015-08-03
KR101636086B1 (ko) 2016-07-04
CA2703493C (en) 2016-11-08
WO2009054433A1 (ja) 2009-04-30
MX2010004397A (es) 2010-06-01
CN101821403A (zh) 2010-09-01
AU2008314973A1 (en) 2009-04-30
BRPI0818764B1 (pt) 2017-11-21
EP2213746A4 (en) 2010-11-24

Similar Documents

Publication Publication Date Title
HK1143404A1 (en) Cell for use in the production of exogenous protein, and production process using the cell
ZA200906061B (en) Use of copper and glutamate in cell culture for production of polypeptides
HK1200483A1 (en) Engineered tissues for in vitro research uses, arrays thereof, and methods of making the same
EP1988153A4 (en) CELL CULTURAL CONTAINER AND METHOD FOR THE PRODUCTION THEREOF
EP2169049A4 (en) CELL CULTURAL CONTAINER AND CELL CUKLTURE PROCESS
EP2214237A4 (en) METHOD FOR PRODUCING ELECTRODE MATERIAL FOR A FUEL CELL, ELECTRODE MATERIAL FOR A FUEL CELL AND FUEL CELL WITH THE ELECTRODE MATERIAL FOR A FUEL CELL
IL202213A0 (en) Recombinant protein production in avian ebxr cells
EP2189519A4 (en) CELL CULTURE INSTRUMENT AND CELL CUKLTURE PROCESS WITH THIS
EP2302690A4 (en) SOLAR BATTERY CELL AND METHOD FOR MANUFACTURING THE SAME
IL209343A0 (en) Differentiated anucleated cells and method for preparing the same
IL210210A0 (en) Improved protein production and storage in plants
EP2343760A4 (en) PROCESS FOR PRODUCING ELECTRODE MATERIAL, ELECTRODE MATERIAL, ELECTRODE AND BATTERY
HK1207883A1 (en) Cell culture method and utilization of the same
EP2014763A4 (en) CONTAINER FOR CELL CULTURE AND METHOD FOR PRODUCING THE SAME
EP2436773A4 (en) METHOD FOR PRODUCING A USEFUL SUBSTANCE AND SURFACE FOR USE IN THE PROCESS
EP2424010A4 (en) METHOD FOR PRODUCING BATTERY ELECTRODES AND COATING NOZZLE USED IN THIS METHOD
HRP20190371T1 (hr) Solarna ćelija i postupak njezine proizvodnje
EP2281881A4 (en) HEFMUTANTE AND SUBSTANCE MANUFACTURING METHOD USING THEREOF
EP2502617A4 (en) PROCESS FOR PRODUCING W / O / W EMULSION, METHOD FOR PRODUCING LIPOSOME USING THE METHOD, AND POROUS MEMBRANE FOR USE IN THE METHODS
EP2194126A4 (en) PROCESS FOR CONSTRUCTING CELLS WITH HIGH PRODUCTIVITY OF FOREIGN PROTEIN
GB0812789D0 (en) Materials and methods for cell growth
HK1147218A1 (en) Stem cell lines, their application and culture methods
EP2265708A4 (en) METHODS OF STEM CELL PRODUCTION AND THERAPY
EP2230309A4 (en) GENE WITH ABILITY TO INCREASE THE PRODUCTION OF OIL AND FAT IN A PLANT AND USE THEREOF
EP2224007A4 (en) GENE CAPABLE OF INCREASING OIL AND FAT PRODUCTION IN A PLANT, AND USE THEREOF

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20191023